Publications by authors named "Ritsuko Nakajima"

Article Synopsis
  • A 39-year-old pregnant woman developed symptoms of gestational diabetes insipidus (DI) after 31 weeks, characterized by excessive thirst and urination, leading to the suspicion of DI based on lab results.
  • Her condition worsened, resulting in acute kidney failure and an emergency cesarean section at 34 weeks, revealing a significantly enlarged placenta.
  • Post-delivery, she received a treatment that resolved her symptoms, and findings indicated that the excessive vasopressinase from the enlarged placenta, along with insufficient vasopressin from the pituitary, contributed to her DI symptoms.
View Article and Find Full Text PDF

Background: Cases of subacute thyroiditis (SAT) after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination have been reported. A human leukocyte antigen (HLA) allele, HLA-B*35, appears to be involved in the pathogenesis of SAT.

Case Presentation: We conducted HLA typing of one patient with SAT and another with both SAT and Graves' disease (GD), which developed after SARS-CoV-2 vaccination.

View Article and Find Full Text PDF

Background: It is important to distinguish benign thyroid nodules from malignant thyroid nodules. Hence, this study aimed to determine the characteristics of patients with thyroid cancer using thyroid ultrasonography.

Methods: We retrospectively examined the ultrasonographic findings of 327 patients with 457 thyroid nodules (age: 59.

View Article and Find Full Text PDF
Article Synopsis
  • A 48-year-old man with parotid gland adenocarcinoma and lung metastasis experienced concurrent onset of Graves' disease and type 1 diabetes after receiving nivolumab treatment for cancer.
  • Fourteen days post the sixth nivolumab course, blood tests revealed high glucose levels (379 mg/dL) and signs of thyrotoxicosis, indicating both autoimmune conditions.
  • The patient had a specific genetic marker (HLA-DRB1*04:05) commonly associated with autoimmune conditions, suggesting a potential link between his genetics and the simultaneous manifestation of type 1 diabetes and Graves' disease following immunotherapy.
View Article and Find Full Text PDF

Objectives: To elucidate the effectiveness and safety of intravenous thrombolysis (IVT) with mutant tissue plasminogen activator prior to percutaneous coronary intervention (PCI) in patients with acute myocardial infarction.

Methods: Ninety consecutive patients were recruited with the following criteria: acute myocardial infarction with ST segment elevation or bundle branch block on electrocardiography, admission within 6 hr from onset, age of < or = 80 years and without previous PCI or coronary bypass graft surgery. They were divided into two groups.

View Article and Find Full Text PDF